| COVAX | VISVX | COVAX / VISVX | |
| Total Expense Ratio | 1.21 | 0.19 | 637% |
| Annual Report Gross Expense Ratio | 1.36 | 0.19 | 716% |
| Fund Existence | 24 years | 28 years | - |
| Gain YTD | -3.017 | 1.971 | -153% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 3000 | 67% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 789M | 58.3B | 1% |
| Annual Yield % from dividends | 1.13 | 1.90 | 59% |
| Returns for 1 year | -17.63 | -2.33 | 756% |
| Returns for 3 years | -15.51 | 23.94 | -65% |
| Returns for 5 years | -5.70 | 55.12 | -10% |
| Returns for 10 years | -19.33 | 103.50 | -19% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SDY | 137.35 | 0.24 | +0.18% |
| State Street® SPDR® S&P® Dividend ETF | |||
| ZAP | 30.09 | -0.01 | -0.02% |
| Global X U.S. Electrification ETF | |||
| NFTY | 59.15 | -0.06 | -0.10% |
| First Trust India NIFTY 50 Equal Wtd ETF | |||
| NUKZ | 64.41 | -0.22 | -0.34% |
| Range Nuclear Renaissance ETF | |||
| SPXV | 72.03 | -0.57 | -0.79% |
| ProShares S&P 500® ex-Health Care | |||